The pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents is effective and relatively safe

被引：0
|
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 2007年 / 23卷 / 11期
关键词：
Adolescents; Amfetamine; therapeutic use; Atomoxetine; Attention deficit hyperactivity disorder; treatment; Bupropion; Central nervous system stimulants; Clonidine;
D O I：
10.2165/00042310-200723110-00003
中图分类号：
学科分类号：
摘要：
Although the treatment of attention-deficit hyperactivity disorder in adolescents brings new challenges, stimulant and nonstimulant medications are likely to be as effective in adolescents as they are in younger children. To ensure coverage of school and extracurricular activities, the use of longer-acting formulations is often required. The risk of adverse effects appears to be outweighed by the benefits of treatmen. © 2007 Adis Data Information BV. All rights reserved.
引用
收藏
页码：9 / 12
页数：3
相关论文
共 50 条
  • [31] Attention-deficit/hyperactivity disorder (ADHD) at the workplace
    Stockreiter, D.
    Reuss, F.
    Holzgreve, F.
    Germann, U.
    Oremek, G.
    Ohlendorf, D.
    Wanke, E. M.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2024, 74 (05): : 234 - 240
  • [32] Editorial: Attention-deficit hyperactivity disorder (ADHD)
    Sayal, Kapil
    CHILD AND ADOLESCENT MENTAL HEALTH, 2015, 20 (02) : e3 - e5
  • [33] Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder
    Biederman, J
    Spencer, T
    BIOLOGICAL PSYCHIATRY, 1999, 46 (09) : 1234 - 1242
  • [34] Insomnia in adults with attention-deficit/hyperactivity disorder (ADHD): impact of clinical subtype and pharmacological treatment
    Brevik, E. J.
    Lundervold, A. J.
    Halmoy, A.
    Posserud, M. -B.
    Instanes, J. T.
    Bjorvatn, B.
    Haavik, J.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 92 - 92
  • [35] Attention-deficit hyperactivity disorder is associated with relatively short stature among adolescents
    Namimi-Halevi, Chen
    Dor, Chen
    Dichtiar, Rita
    Bromberg, Michal
    Sinai, Tali
    ACTA PAEDIATRICA, 2023, 112 (04) : 779 - 786
  • [36] Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
    Sumner C.R.
    Gathercole S.
    Greenbaum M.
    Rubin R.
    Williams D.
    Hollandbeck M.
    Wietecha L.
    Child and Adolescent Psychiatry and Mental Health, 3 (1)
  • [37] Pharmacological management of attention-deficit hyperactivity disorder in adolescents - Special considerations
    Hazell, Philip
    CNS DRUGS, 2007, 21 (01) : 37 - 46
  • [38] Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes
    Adamo, Nicoletta
    Seth, Sarah
    Coghill, David
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (04) : 383 - 397
  • [39] Public perspectives on pharmacological treatment of attention-deficit hyperactivity disorder
    Nam, B.
    Shon, I.
    Kim, M. H.
    Seo, J. S.
    Jung, Y. E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S651 - S652
  • [40] Pharmacological management of attention-deficit hyperactivity disorder
    Reeves, G
    Schweitzer, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) : 1313 - 1320
12345